Trade INCY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Incyte Corp. (INCY) is trading at US$125.31, down 1.81% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$25.91B. Over the past 52 weeks, INCY has traded between US$81.09 and US$132.60. On Syfe you can trade INCY with $0 commission and add it to your watchlist.
| Previous close | US$127.62 |
|---|---|
| Market cap | US$25.91B |
| P/E ratio | 17.36 |
| 52-week range | US$81.09 – US$132.60 |
| Volume | 3.7M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Incyte Corp.
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.
Year: 1993
Canaccord Genuity Initiates Incyte at Buy With $152 Price Target
Aug 20, 11:35 AM · MT Newswires
Incyte Corp. (INCY) stock is trading at US$125.31, -1.81% from the previous close of US$127.62.
The market cap for Incyte Corp. (INCY) stock is approximately US$25.91B.
The price-to-earnings ratio for Incyte Corp. (INCY) is 17.36, based on the latest reported earnings.
The 52-week high for Incyte Corp. (INCY) stock is US$132.60.
The 52-week low for Incyte Corp. (INCY) stock is US$81.09.
Incyte Corp. (INCY) does not currently pay a dividend.
Stay on top of INCY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
